Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026February › 04

Nordisk

5 months ago

Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition

The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in reven…

Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise prereleased its 2026 forecast late Tuesday, sending shares tumbling.
Danish drugmaker reports rise in revenues but flags pricing pressure as market becomes more crowded

page 1 of 1